May 30, 2023 4:11 AM
BACK TO TOP
KSE100
41,340.06
375.52
(0.92%)
ALLSHR
27,650.12
234.10
(0.85%)
KSE30
14,663.46
131.53
(0.91%)
KMI30
71,074.87
786.38
(1.12%)
BKTI
9,233.22
-11.53
(-0.12%)
OGTI
10,462.13
108.52
(1.05%)
KMIALLSHR
20,037.69
197.55
(1.00%)
PSXDIV20
14,476.18
24.18
(0.17%)
UPP9
12,147.21
102.55
(0.85%)
NITPGI
9,632.42
95.22
(1.00%)
NBPPGI
11,089.14
95.12
(0.87%)
MZNPI
8,639.87
84.45
(0.99%)
JSMFI
9,167.11
2.39
(0.03%)
ACI
6,821.42
44.41
(0.66%)
HBLTTI
11,332.66
26-05-2023
19.69
(0.17%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.81.81
-0.64
(-0.78%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, May 29, 2023 4:00 PM
REG
FUT
ODL
Open
80.30
High
82.35
Low
80.30
Volume
11,600
CIRCUIT BREAKER
76.27 — 88.63
DAY RANGE
80.30 — 82.35
52-WEEK RANGE
73.00 — 128.50
Ask Price
81.81
Ask Volume
0
Bid Price
81.81
Bid Volume
5,000
LDCP
82.45
VAR
13.50
HAIRCUT
17.50
P/E Ratio (TTM) **
13.24
1-Year Change *
-35.04%
YTD Change *
-6.79%

No record found

Open
0.00
High
81.60
Low
81.60
Close
81.60
Change
-1.03%
LDCP
82.45
Volume
1
Total Trades
1
CIRCUIT BREAKER
74.21 — 90.70
DAY RANGE
81.60 — 81.60
Ask Price
89.00
Ask Volume
10
Bid Price
81.70
Bid Volume
6
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Ms. Erum Shakir RahimCEO
Ms. Lai Kuen GohChairman
Ms. Mehar-e-daraksha AmeerCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
26,053,808.01
Shares
318,467,278
Free Float
52,146,090
Free Float
16.37%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
May 3, 2023Transmission of Annual Report for the Year Ended December 31, 2022 View   PDF
Apr 28, 2023Transmission of Quarterly Report for the Period Ended March 31, 2023 View   PDF
Apr 27, 2023Financial Results For The Quarter Ended March 31, 2023 View   PDF
Mar 17, 2023Applied for Extension for Holding AGM for the Year ended 2022-12-31 View   PDF
Feb 9, 2023Financial Results for the Year Ended December 31, 2022 View   PDF
Oct 28, 2022Transmission of Quarterly Report for the Period Ended September 30, 2022 View   PDF
Oct 25, 2022Financial Results for the Quarter Ended September 30, 2022 View   PDF
Aug 29, 2022Transmission of Quarterly Report for the Period Ended June 30, 2022 View   PDF
Aug 23, 2022Financial Results for the Quarter Ended June 30, 2022 View   PDF
May 6, 2022Transmission of Quarterly Report for the Period Ended March 31, 2022 View   PDF
DateTitleDocument
May 24, 2023Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on May 24, 2023 View   PDF
May 3, 2023Notice of Annual General Meeting View   PDF
Apr 20, 2023Board of Directors Meeting View   PDF
Apr 20, 2023Notice of Annual General Meeting - Prior Publication View   PDF
Mar 27, 2023Approval of Extension in Time for Holding the Annual General Meeting View   PDF
Feb 2, 2023Board Meeting - 4th Quarter 2022 on 9 February 2023 View   PDF
Oct 18, 2022Board Meeting View   PDF
Aug 16, 2022Board of Directors Meeting - August 23, 2022 View   PDF
Apr 25, 2022Board Meeting In Progress View   PDF
Apr 25, 2022Certified True Copy of Resolution - Annual General Meeting View   PDF
Apr 18, 2022Board Meeting View   PDF
DateTitleDocument
May 17, 2023Notice of Election of Directors View   PDF
Apr 5, 2023RESCHEDULING OF AGM AND BOOK CLOSURE DATES View   PDF
Nov 24, 2022Notice of Corporate Briefing Session 2022 View   PDF
Sep 28, 2022Appointment of Non-Executive Director View   PDF
Sep 28, 2022Appointment of Non-Executive Director View   PDF
Sep 16, 2022GLAXO | GlaxoSmithKline Pakistan Limited
REVISED
PDF
Sep 16, 2022GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information
REVOKED
PDF
Aug 12, 2022Appointment of Ms. Lai Kuen Goh - Chairperson and Non-Executive Director View   PDF
Aug 10, 2022Resignation of Mr. Dmytro Oliinyk from the Board of GlaxoSmithKline Pakistan Limited View   PDF
Jun 30, 2022Material Information - Resignation of Mark Dawson as Director w.e.f. 30 June 2022 View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2022202120202019
Sales41,841,58536,660,77235,090,11236,581,749
Profit after Taxation2,462,8925,354,4093,375,2403,041,123
EPS7.7316.8110.609.55
Q1 2023Q3 2022Q2 2022Q1 2022
Sales11,399,12011,925,6629,542,3778,625,964
Profit after Taxation430,562148,664(293,829)925,041
EPS1.350.47(0.92)2.90
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2022202120202019
Gross Profit Margin (%)17.4026.5621.4721.08
Net Profit Margin (%)5.8914.619.628.31
EPS Growth (%)(54.02)58.5810.99(6.65)
PEG(0.21)0.141.65(2.53)

Payouts

DateFinancial ResultsDetailsBook Closure
February 28, 2022 11:32 AM31/12/2021(YR) 70%(F) (D) 19/04/2022 - 25/04/2022
March 10, 2021 3:45 PM31/12/2020(YR) 65%(F) (D) 21/04/2021 - 27/04/2021
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014

Financial Reports